Pathalys Pharma
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$105M
Pathalys Pharma is a biopharmaceutical company developing advanced therapeutics for end-stage kidney disease (ESKD).
Focus Areas
biopharmaceutical
clinical trials
calcimimetic
NDA filing
FDA
end-stage kidney disease
Investors
